Siamak Daneshmand
University of Southern California(US)The University of Texas Health Science Center at San Antonio(US)Duke University(US)Keck Hospital of USC(US)UC San Diego Health System(US)USC Norris Comprehensive Cancer Center(US)Duke University Hospital(US)The University of Texas at San Antonio(US)University of Pennsylvania(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Urological Disorders and Treatments, Testicular diseases and treatments, Renal cell carcinoma treatment
Most-Cited Works
- → Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer(2017)2,447 cited
- → Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline(2016)1,353 cited
- → Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes(2015)672 cited
- → ctDNA guiding adjuvant immunotherapy in urothelial carcinoma(2021)584 cited
- → Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial(2021)399 cited
- → Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes(2013)358 cited